Gå offline med appen Player FM !
Podcasts der er værd at lytte til
SPONSORERET
![Travis Makes Money podcast artwork](https://cdn.player.fm/images/32243849/series/wgCXadnk2StIFlzM/32.jpg 32w, https://cdn.player.fm/images/32243849/series/wgCXadnk2StIFlzM/64.jpg 64w, https://cdn.player.fm/images/32243849/series/wgCXadnk2StIFlzM/128.jpg 128w, https://cdn.player.fm/images/32243849/series/wgCXadnk2StIFlzM/256.jpg 256w, https://cdn.player.fm/images/32243849/series/wgCXadnk2StIFlzM/512.jpg 512w)
![Travis Makes Money podcast artwork](/static/images/64pixel.png)
1 Make Money with AI Appointment Setting | Matt Deseno 32:38
Triple Negative Breast Cancer: Immunotherapies and Biomarkers
Manage episode 323367288 series 2812899
In this episode, we discuss the treatment of triple negative breast cancer (TNBC) with Dr. Stephen Chia. We cover:
- The use of immunotherapies to treat TNBC
- Biomarkers that can determine which patients will best respond to immunotherapies
- The challenges of testing for PDL-1
Our Guest:
Dr. Stephen Chia is a professor in the division of medical oncology and staff medical oncologist with BC Cancer, in Vancouver. He has held many leadership roles at BC Cancer, including Head of the Division of Medical Oncology UBC, Head of the Department of Clinical Research, BC Cancer, and Chair of the BC Cancer Breast Tumour Group. He has also been the Co-Chair of the Breast Disease Site for Canadian Cancer Trials Group (CCTG).
This podcast episode was sponsored by Merck Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 episoder
Manage episode 323367288 series 2812899
In this episode, we discuss the treatment of triple negative breast cancer (TNBC) with Dr. Stephen Chia. We cover:
- The use of immunotherapies to treat TNBC
- Biomarkers that can determine which patients will best respond to immunotherapies
- The challenges of testing for PDL-1
Our Guest:
Dr. Stephen Chia is a professor in the division of medical oncology and staff medical oncologist with BC Cancer, in Vancouver. He has held many leadership roles at BC Cancer, including Head of the Division of Medical Oncology UBC, Head of the Department of Clinical Research, BC Cancer, and Chair of the BC Cancer Breast Tumour Group. He has also been the Co-Chair of the Breast Disease Site for Canadian Cancer Trials Group (CCTG).
This podcast episode was sponsored by Merck Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
68 episoder
すべてのエピソード
×![Artwork](/static/images/128pixel.png)
1 Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape 17:37
![Artwork](/static/images/128pixel.png)
1 Highlights from EHA 2024 - Updates on the Treatment of CLL 42:13
![Artwork](/static/images/128pixel.png)
1 LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL 16:33
![Artwork](/static/images/128pixel.png)
1 Cutting Edge Advances in the Treatment of Lung Cancer 15:13
![Artwork](/static/images/128pixel.png)
1 Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers 41:28
![Artwork](/static/images/128pixel.png)
1 Immunotherapy for Kidney Transplant Patients with Skin Cancer 21:32
![Artwork](/static/images/128pixel.png)
1 Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective 24:11
![Artwork](/static/images/128pixel.png)
1 LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM 16:58
![Artwork](/static/images/128pixel.png)
1 Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL 13:48
![Artwork](/static/images/128pixel.png)
1 First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC 32:28
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion 26:41
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion 8:07
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment 14:52
![Artwork](/static/images/128pixel.png)
1 First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs 10:38
Velkommen til Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.